Innovation in continuous renal replacement therapies (CRRT) utilized to treat acute kidney injury (AKI) and sepsis, has brought new machines and techniques. Part of these new advances are due to the availability of innovative biomaterials and the construction of membranes with larger pores and wide distribution of pore sizes. This includes the creation of a new generation of high cut-off membranes whose utilization in clinical practice is promising for the wide spectrum of solutes that are removed during extracorporeal therapies.
However, the enlargement of pore diameters brings some loss of albumin during treatment and this effect is still under evaluation, since there is a possibility that this is detrimental for the patient. A thorough review of the available clinical literature is reported in this paper with a reappraisal of the potential application of these new technologies.
Boschetti-de-FierroA., VoigtM., StorrM., KrauseB.Extended characterization of a new class of membranes for blood purification: the high cut-off membranes.Int J Artif Organs.2013; 36(7): 455–463.
8.
VillaG., ZaragozaJ.J., SharmaA., NeriM., De GaudioA.R., RoncoC.Cytokine removal with high cut-off membrane: review of literature.Blood Purif.2014; 38(3-4): 167–173.
9.
HutchisonC.A., HardingS., MeadG.Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care.Artif Organs.2008; 32(12): 910–917.
MorgeraS., RocktäschelJ., HaaseM.Intermittent high permeability hemofiltration in septic patients with acute renal failure.Intensive Care Med.2003; 29(11): 1989–1995.
12.
MorgeraS., HaaseM., RocktäschelJ.Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure.Nephron Clin Pract.2003; 94(3): c75–c80.
13.
MorgeraS., SlowinskiT., MelzerC.Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status.Am J Kidney Dis.2004; 43(3): 444–453.
14.
MorgeraS., HaaseM., KussT.Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure.Crit Care Med.2006; 34(8): 2099–2104.
15.
HaaseM., BellomoR., BaldwinI.Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial.Am J Kidney Dis.2007; 50(2): 296–304.
16.
KadeG., LubasA., RzeszotarskaA., KorsakJ., NiemczykS.Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.Med Sci Monit.2016; 22: 4338–4344.
17.
ChelazziC., VillaG., DAlfonsoM.G.Hemodialysis with High Cut-Off Hemodialyzers in Patients with Multi-Drug Resistant Gram-Negative Sepsis and Acute Kidney Injury: A Retrospective, Case-Control Study.Blood Purif.2016; 42(3): 186–193.
18.
AtanR., PeckL., VisvanathanK.High cut-off hemofiltration versus standard hemofiltration: effect on plasma cytokines.Int J Artif Organs.2016; 39(9): 479–486.
19.
VillaG., ChelazziC., MorettiniE.Organ dysfunction during continuous veno-venous high cut-off hemodialysis in patients with septic acute kidney injury: A prospective observational study.PLoS One.2017; 12(2): e0172039.
20.
OSullivanS.T., LedererJ.A., HorganA.F., ChinD.H., MannickJ.A., RodrickM.L.Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.Ann Surg.1995; 222(4): 482–490, discussion 490–492.
21.
De VrieseA.S., VanholderR.C., PascualM., LameireN.H., ColardynF.A.Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?Intensive Care Med.1999; 25(9): 903–910.
RhodesA., EvansL.E., AlhazzaniW.Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.Crit Care Med.2017; 45(3): 486–552.
24.
ZhangL., KangY., FuP.Myoglobin clearance by continuous venous-venous haemofiltration in rhabdomyolysis with acute kidney injury: a case series.Injury.2012; 43(5): 619–623.
25.
VillaG., CassettaM.I., TofaniL.Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients.Int J Antimicrob Agents.2015; 46(4): 465–468.
26.
KrieterD.H., DevineE., WannerC., StorrM., KrauseB., LemkeH.D.Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysis.Artif Organs.2014; 38(10): 888–893.
27.
Kidney Disease Improving Global Outcomes (KDIGO)Clinical Practice Guideline for Acute Kidney Injury.Kidney Int Suppl.2012; 2: 1–138.
28.
BonaviaA., MillerL., KellumJ.A., SingbartlK.Hemoadsorption corrects hyperresistinemia and restores anti-bacterial neutrophil function.Intensive Care Med Exp2017; 5: 1–36.
29.
MantzarlisK., TsolakiV., ZakynthinosE.Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies.Oxid Med Cell Longev.2017; 2017: 5985209.
30.
PengZ., SingbartlK., SimonP.Blood purification in sepsis: a new paradigm.Contrib Nephrol2010; 165: 322–328.
31.
AtariR., CrosbieD., BellomoR.Techniques of extracorporeal cytokine removal: a systematic review of the literature on animal experimental studies.Int J Artif Organs.2013; 36(3): 149–158.
32.
MuruganR., WenX., KeenerC.Biological Markers of Recovery for the Kidney (BioMaRK) Study Investigators. Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes.Clin J Am Soc Nephrol.2015; 10(6): 926–933.
33.
HollanderS.A., BernsteinD., YehJ., DaoD., SunH.Y., RosenthalD.Outcomes of children following a first hospitalization for dilated cardiomyopathy.Circ Heart Fail.2012; 5(4): 437–443.
34.
MoriguchiT., KoizumiK., MatsudaK.Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities.J Artif Organs.2017; 20(3): 236–243. Epub ahead of print.
35.
Shankar-HariM., FearD., LavenderP.Activation-Associated Accelerated Apoptosis of Memory B Cells in Critically III Patients With Sepsis.Crit Care Med.2017; 45(5): 875–882.
36.
BonaviaA., SingbartlK.A review of the role of immune cells in acute kidney injury.Pediatr Nephrol.2017. Epub ahead of print. doi: 10.1007/s00467-017-3774-5.
37.
PupelisG., PlaudisH., ZeizaK., DrozdovaN., MukansM., KazakaI.Early continuous veno-venous haemofiltration in the management of severe acute pancreatitis complicated with intraabdominal hypertension: retrospective review of 10 years experience.Ann Intensive Care2012; 2(Suppl 1): S21.
38.
LarsenF.S., SchmidtL.E., BernsmeierC.High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.J Hepatol.2016; 64(1): 69–78.
39.
FanelliV., RanieriV.M.Mechanisms and clinical consequences of acute lung injury.Ann Am Thorac Soc2015; 12(Suppl 1): S3–S8.
40.
CamussiG., RoncoC., MontrucchioG., PiccoliG.Role of soluble mediators in sepsis and renal failure.Kidney Int Suppl1998; 66: S38–S42.
41.
BellomoR., RoncoC.Blood purification in the intensive care unit: evolving concepts.World J Surg.2001; 25(5): 677–683.
42.
BellomoR., RoncoC.Acute renal failure in the intensive care unit: adequacy of dialysis and the case for continuous therapies.Nephrol Dial Transplant.1996; 11(3): 424–428.
43.
RoncoC., BrendolanA., DanM.Adsorption in sepsis.Kidney Int Suppl2000; 58: S148–S155.
44.
RoncoC., BrendolanA., CrepaldiC., RodighieroM., ScabardiM.Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique.J Am Soc Nephrol2002; 13(Suppl 1): S53–S61.
45.
CruzD.N., PerazellaM.A., BellomoR.Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review.Am J Kidney Dis.2006; 48(3): 361–371.
46.
RoncoC., BrendolanA., BragantiniL.Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration.Kidney Int.1986; 29(4): 908–915.
47.
RoncoC., Di LulloL.Cardiorenal syndrome.Heart Fail Clin.2014; 10(2): 251–280.
48.
TagayaM., NagoshiS., MatsudaM., TakahashiS., OkanoS., HaraK.Hemodialysis membrane coated with a polymer having a hydrophilic blood-contacting layer can enhance diffusional performance.Int J Artif Organs2017; doi: 10.5301/ijao.5000631 [Epub ahead of print].
49.
HartmannJ., HarmS.A new integrated technique for the supportive treatment of sepsis.Int J Artif Organs.2017; 40(1): 4–8.
50.
YuanK.C., WangS.Y., YuM.C., HsuY.P., PanH.C., ChenY.C.Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis.Int J Artif Organs.2017; 39(12): 603–610.
51.
TagayaM., TakahashiS., MatsudaM., TakasakiT., HamaishiM., HaraK.Prospects for clinical applications of polymer-coated haemoconcentrator on extracorporeal circuit in cardiopulmonary bypass surgeries.Int J Artif Organs.2016; 39(8): 415–420.
52.
TrägerK., FritzlerD., FischerG., SchröderJ., SkrabalC., LieboldA., ReineltH.Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series.Int J Artif Organs.2016; 39(3): 141–146.
